{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:48Z","timestamp":1707524808884},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,25]]},"DOI":"10.7759\/cureus.31882","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:34:07Z","timestamp":1669379647000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Atypical Hairy Cell Leukemia With CD10+ and CD38+: Diagnosis and Treatment"],"prefix":"10.7759","author":[{"given":"Tung","family":"Tuan Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Thi Vinh Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong","family":"Phan Thi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Lan Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Tam","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V13.7.609.609","article-title":"Leukemic reticuloendotheliosis","volume":"13","author":"Bouroncle BA","year":"1958","unstructured":"Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958, 13:609-30.","journal-title":"Blood"},{"key":"ref2","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Publications, Lyon, France; 2008."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras LR","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016, 66:443-59. 10.3322\/caac.21357","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v8i10.2259","article-title":"Epidemiology of hairy cell leukemia (HCL) and HCL-like disorders","volume":"8","author":"Troussard X","year":"2020","unstructured":"Troussard X. Epidemiology of hairy cell leukemia (HCL) and HCL-like disorders. Med Res Arch. 2020, 8:10.18103\/mra.v8i10.2259","journal-title":"Med Res Arch"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci E","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavoni G, et al.. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011, 364:2305-15. 10.1056\/NEJMoa1014209","journal-title":"N Engl J Med"},{"key":"ref6","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes E","year":"1994","unstructured":"Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma. 1994, 14:57-61.","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12824","article-title":"Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL","volume":"40","author":"Favre R","year":"2018","unstructured":"Favre R, Manzoni D, Traverse-Glehen A, et al.. Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL. Int J Lab Hematol. 2018, 40:e59-62. 10.1111\/ijlh.12824","journal-title":"Int J Lab Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1309\/8qytyq1clqmhq9cl","article-title":"Hairy cell leukemia variant: fact or fiction","volume":"123","author":"Cessna MH","year":"2005","unstructured":"Cessna MH, Hartung L, Tripp S, Perkins SL, Bahler DW. Hairy cell leukemia variant: fact or fiction. Am J Clin Pathol. 2005, 123:132-8. 10.1309\/8qytyq1clqmhq9cl","journal-title":"Am J Clin Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041050","article-title":"Immunophenotypic analysis of hairy cell leukemia (HCL) and hairy cell leukemia-like (HCL-like) disorders","volume":"14","author":"Maitre E","year":"2022","unstructured":"Maitre E, Cornet E, Sala\u00fcn V, et al.. Immunophenotypic analysis of hairy cell leukemia (HCL) and hairy cell leukemia-like (HCL-like) disorders. Cancers (Basel). 2022, 14:1050. 10.3390\/cancers14041050","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1309\/QVJD31TEG9UJ18BQ","article-title":"Analysis of CD10+ hairy cell leukemia","volume":"120","author":"Jasionowski TM","year":"2003","unstructured":"Jasionowski TM, Hartung L, Greenwood JH, Perkins SL, Bahler DW. Analysis of CD10+ hairy cell leukemia. Am J Clin Pathol. 2003, 120:228-35. 10.1309\/QVJD31TEG9UJ18BQ","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1309\/PMQXVY619Q8Y43AR","article-title":"Immunophenotypic variations in hairy cell leukemia","volume":"125","author":"Chen YH","year":"2006","unstructured":"Chen YH, Tallman MS, Goolsby C, Peterson L. Immunophenotypic variations in hairy cell leukemia. Am J Clin Pathol. 2006, 125:251-9. 10.1309\/PMQXVY619Q8Y43AR","journal-title":"Am J Clin Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0893","article-title":"CD38 in hairy cell leukemia is a marker of poor prognosis and a new target for therapy","volume":"75","author":"Poret N","year":"2015","unstructured":"Poret N, Fu Q, Guihard S, et al.. CD38 in hairy cell leukemia is a marker of poor prognosis and a new target for therapy. Cancer Res. 2015, 75:3902-11. 10.1158\/0008-5472.CAN-15-0893","journal-title":"Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123651-a-case-of-atypical-hairy-cell-leukemia-with-cd10-and-cd38-diagnosis-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:18Z","timestamp":1707507738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123651-a-case-of-atypical-hairy-cell-leukemia-with-cd10-and-cd38-diagnosis-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.31882","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,25]]}}}